• Allen, D.G. & Monteiro-Riviere, N.A. (1999) Alteration of cytokeratin expression following transdermal lidocaine hydrochloride iontophoresis. Pharmaceutical Research, 16, 14871490.
  • FDA-CVM (2002) Guidance for Industry: Bioequivalence Guidance. Rockville, MD.
  • Feldmann, R.J. & Maibach, H.I. (1967) Regional variation in percutaneous penetration of 14C cortisol in man. Journal of Investigative Dermatology, 48, 181183.
  • Freise, K.J., Savides, M.C., Riggs, K.L., Owens, J.G., Newbound, G.C. & Clark, T.P. (2012) Pharmacokinetics and dose selection of a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles. Journal of Veterinary Pharmacology and Therapeutics, 35(Suppl. 2), 2126.
  • Gourlay, G.K., Kowalski, S.R., Plummer, J.L., Cousins, M.J. & Armstrong, P.J. (1988) Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesthesia and Analgesia, 67, 329337.
  • Hofmeister, E.H. & Egger, C.M. (2004) Transdermal fentanyl patches in small animals. Journal of the American Animal Hospital Association, 40, 468478.
  • Kyles, A.E., Papich, M. & Hardie, E.M. (1996) Disposition of transdermally administered fentanyl in dogs. American Journal of Veterinary Research, 57, 715719.
  • Magnusson, B.M., Walters, K.A. & Roberts, M.S. (2001) Veterinary drug delivery: potential for skin penetration enhancement. Advanced Drug Delivery Reviews, 50, 205227.
  • Monteiro-Riviere, N.A. (1990) Altered epidermal morphology secondary to lidocaine iontophoresis: in vivo and in vitro studies in porcine skin. Fundamental and Applied Toxicology, 15, 174185.
  • Monteiro-Riviere, N.A., Bristol, D.G., Manning, T.O., Rogers, R.A. & Riviere, J.E. (1990) Interspecies and interregional analysis of the comparative histologic thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species. Journal of Investigative Dermatology, 95, 582586.
  • Mukhtar, H. (1992) Pharmacology of the Skin. CRC Press, Boca Ratonm, FL.
  • Murphy, M.R., Hug, C.C. Jr & McClain, D.A. (1983) Dose-independent pharmacokinetics of fentanyl. Anesthesiology, 59, 537540.
  • Pascoe, P.J. (2000) Opioid analgesics. The Veterinary Clinics of North America. Small Animal Practice, 30, 757772.
  • Plumb, D.C. (2008) Plumb’s Veterinary Drug Handbook. Blackwell Publishing, Ames, IA.
  • Riviere, J.E., Monteiro-Riviere, N.A. & Inman, A.O. (1992) Determination of lidocaine concentrations in skin after transdermal iontophoresis: effects of vasoactive drugs. Pharmaceutical Research, 9, 211214.
  • Sano, T., Nishimura, R., Kanazawa, H., Igarashi, E., Nagata, Y., Mochizuki, M. & Sasaki, N. (2006) Pharmacokinetics of fentanyl after single intravenous injection and constant rate infusion in dogs. Veterinary Anaesthesia and Analgesia, 33, 266273.
  • Savides, M.C., Pohland, R.C., Wilkie, D.A., Abbott, J.A., Newbound, G.C., Freise, K.J. & Clark, T.P. (2012) The margin of safety of a single application of transdermal fentanyl solution when administered at multiples of the therapeutic dose to laboratory dogs. Journal of Veterinary Pharmacology and Therapeutics, 35(Suppl. 2), 3543.
  • Smith, F.M., Scott, R.C. & Foster, J.R. (1990). An interspecies comparison of skin structure (hair follicle area s determined by a novel technique) and skin permeability. In Skin Pharmacology and Toxicology. Eds Galli, C.L., Hensby, C.N. & Marinovich, M. pp. 299305. Plenum, New York.
  • Veng-Pedersen, P. (2001) Noncompartmentally-based pharmacokinetic modeling. Advanced Drug Delivery Reviews, 48, 265300.